Researchers believe that combining immunotherapy with traditional therapies such as radiation could open up new possibilities for cancer treatment.
Rigor académico, oficio periodístico
Artículos sobre Immunotherapy
Mostrando 41 - 51 de 51 artículos
New treatment options for cancer have flowed from our knowledge of how cells work, including the realisation the patient’s own immune system is a powerful agent in defeating cancer.
Jimmy Carter is now cancer-free, but is it right to say that he’s been cured?
New immunotherapy drugs that enhance the body’s natural ability to fight cancer offer several key advantages over previous treatments.
Take two of medicine’s great foes and pit them against each other.
If you can’t find the specific T cells you need to fight a cancer, make them.
Immunotherapy has joined anti-retroviral drug therapy as a means to combat HIV.
Drugs that help the immune system recognise cancer are very promising.
Immune cells in the blood primarily defend us against infection. But we’re now learning that these cells can also keep us free from cancer. Patients with less efficient immune systems such as organ transplant…
The trouble with treating cancer is that each type has its own quirks. The quirks of pancreatic cancer make it one of the most lethal. The survival period after diagnosis is only four to six months. The…
Immunotherapy is treatment that boosts the body’s immune system by producing more infection-fighting agents, such as white blood cells and antibodies, to help fight disease. While it may seem a modern…
Principales colaboradores
-
Professor of Biomedical Sciences, Anglia Ruskin University
-
Professor of Neurosurgery, University of Florida
-
Associate Professor & Head of Projects, York St John University
-
Professor of One Health, York St John University
-
Professor of Sociology, Ball State University
-
Postdoctoral research scientist, Columbia University
-
Oncologist and Senior Lecturer, University of Newcastle
-
CRUK Senior Lecturer Head and Neck Surgery, University of Southampton
-
Senior Research Fellow, University of Technology Sydney
-
Professor of Health Economics, University of Technology Sydney
-
Professor of Virology, University of Reading
-
Director of Drug Discovery at MRC Technology and Honorary Professor, Queen Mary University of London
-
Professor of Experimental Cancer Research, University of Southampton
-
Executive Director Cancer Research Head, Cancer Immunology Program Professor, Peter MacCallum Cancer Centre
-
Professor of Interdisciplinary Parasitology, University of Nottingham
